A retrospective study of risk factors of Mucormycosis in COVID-19 patients at a dedicated COVID hospital
National Journal of Physiology, Pharmacy and Pharmacology
; 12(9):1393-1398, 2022.
Article
in English
| ProQuest Central | ID: covidwho-2025154
ABSTRACT
Over use of steroids, uncontrolled blood sugar levels, oxygen therapy, long hospital stay, and ICU procedures and ventilators also contribute to the increased occurrence of post-COVID Mucormycosis. Hot and humid climate favors the growth of such molds. [...]many studies have found that hospitals in our country have very heavy mold spore count. [...]steroid-induced hyperglycemia may also be an important risk factor for COVID-associated Mucormycosis. [...]the present retrospective cross-sectional study was planned to study and analyze the risk factors of COVID 19 associated Mucormycosis infection.
Pharmacy And Pharmacology; Infections; Medical records; Patients; Population; Diabetes; COVID-19 vaccines; Ventilators; Severe acute respiratory syndrome coronavirus 2; Cross-sectional studies; Steroids; Sinuses; Hypertension; Risk factors; Oxygen therapy; Hospitals; Antigens; Ethics; Coronaviruses; Intensive care; Males; Farmworkers; Statistical analysis; India
Full text:
Available
Collection:
Databases of international organizations
Database:
ProQuest Central
Type of study:
Observational study
/
Prognostic study
Language:
English
Journal:
National Journal of Physiology, Pharmacy and Pharmacology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS